Inspire Medical Systems, Inc. (INSP) NYSE
44.06
+0.71(+1.64%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
44.06
+0.71(+1.64%)
Currency In USD
| Previous Close | 43.35 |
| Open | 43.86 |
| Day High | 44.69 |
| Day Low | 42.85 |
| 52-Week High | 160.65 |
| 52-Week Low | 42.84 |
| Volume | 827,825 |
| Average Volume | 1.14M |
| Market Cap | 1.27B |
| PE | 10.01 |
| EPS | 4.4 |
| Moving Average 50 Days | 54.66 |
| Moving Average 200 Days | 80.39 |
| Change | 0.71 |
Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum
GlobeNewswire Inc.
Mar 03, 2026 1:00 PM GMT
MINNEAPOLIS, March 03, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstru
Inspire Medical Systems, Inc. Announces Preliminary Unaudited Revenue Results for the Fourth Quarter and Full Year 2025 and Provides Initial 2026 Revenue Guidance
GlobeNewswire Inc.
Jan 12, 2026 11:45 AM GMT
Inspire Announces Appointment of Matt Osberg as Executive Vice President and Chief Financial Officer Joining the Company in the First Quarter of 2026MINNEAPOLIS, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire
Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026
GlobeNewswire Inc.
Jan 07, 2026 1:00 PM GMT
MINNEAPOLIS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the fourth quarter and full year 2025 after the close of trading on Wednesday, February 11. Inspire’s management